Ovarian/Gynecological Cancer - Medical Oncology Clinical Trials Resources
Listed below are the Ovarian/Gynecological Cancer - Medical Oncology Clinical Trials offered at the Kaiser Permanente Santa Clara Medical Center.
| Title: | A PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PAZOPANIB MONOTHERAPY VERSUS PLACEBO IN WOMEN WHO HAVE NOT PROGRESSED AFTER FIRST LINE CHEMOTHERAPY FOR EPITHELIAL OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER” |
|---|---|
| Phase: | III |
| Modality: | Chemotherapy drug |
| Sponsors and Collaborators: | GlaxoSmithKline (GSK) |
| Protocol Number: | GSK VEG110655 |
| Weblink: | LINK TO THE WEB SITE |
ONGOING STUDIES BUT CLOSED TO NEW PARTICIPANTS |
|---|
| Title: | A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE EFFICACY AND SAFETY OF GDC-0449 AS MAINTENANCE THERAPY IN PATIENTS WITH OVARIAN CANCER IN A SECOND OR THIRD COMPLETE REMISSION |
|---|---|
| Phase: | II |
| Modality: | Chemotherapy and Radiation |
| Sponsors and Collaborators: | Genentech |
| Protocol Number: | SHH4489g |
| Weblink: | LINK TO THE WEB SITE |
